EPO-MED

In Epo-med, we are developing novel peptide which can block erythropoientin needed for the cancer cell to survive and grow. In collaboration with Oita University, we are seeking to make part of peptide into a small molecule drug which was extremly difficult to conduct with currently available technology.

Also known as: Epo-Med Inc.